Decoy Therapeutics Raises $3.85M via Warrant Inducement at $3.25
DCOY sits 73% above its 52-week low of $2.18 on elevated volume (54× avg).
Summary
Decoy Therapeutics announced a warrant inducement transaction with an existing institutional investor, generating $3.85 million in gross proceeds. The investor will immediately exercise 1,184,434 Series B Milestone Warrants at a reduced price of $3.25 per share, down from $5.91. In return, the investor receives new unregistered warrants to purchase up to 2,368,868 shares at $3.25, exercisable upon stockholder approval. The company intends to use net proceeds for working capital and general corporate purposes. This follows a June private placement that raised $3.5 million upfront and a recent 10-Q warning of going concern doubts and Nasdaq delisting risk. The transaction provides near-term liquidity but adds potential dilution from the new warrants.
At the time of this announcement, DCOY was trading at $3.78 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.5M. The 52-week trading range was $2.18 to $55.92. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: PR Newswire.